Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (61-70 of 328) with videos related to

Pageof 33
Sort By:
AIDS (London, England)|December 7, 2006
Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cellsMorgane Bomsel, Claudia Pastori, Daniela Tudor, et al.
AIDS (London, England)|April 13, 2004
Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients: 24-week immunological outcomeNicola Gianotti, Alessandro Soria, Laura Galli, et al.
The New Microbiologica|September 7, 2007
Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapyAnna De Bona, Laura Galli, Giulia Gallotta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2009
Changes in darunavir/r resistance score after previous failure to tipranavir/r in HIV-1-infected multidrug-resistant patientsVincenzo Spagnuolo, Nicola Gianotti, Elena Seminari, et al.
AIDS (London, England)|July 11, 2003
Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administrationSimona Porcellini, Giuliana Vallanti, Silvia Nozza, et al.
Cytometry. Part B, Clinical Cytometry|May 3, 2007
Does cyclosporin A affect CCR5 and CXCR4 expression in primary HIV-1-infected patients?Priscilla Biswas, Andrea Galli, Laura Galli, et al.
Journal of Clinical Microbiology|May 31, 2002
Direct detection of Helicobacter pylori mutations associated with macrolide resistance in gastric biopsy material taken from human immunodeficiency virus-infected subjectsPaolo Scarpellini, Paola Carrera, Annalisa Cavallero, et al.
AIDS (London, England)|September 10, 2003
Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individualsAnna Maria Brambilla, Roberto Novati, Giliola Calori, et al.
HIV Clinical Trials|June 29, 2005
Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in ItalyJohn Hornberger, Jesse Green, Neil Wintfeld, et al.
The New Microbiologica|January 11, 2017
Dynamic change in the NS3 protease domain in HIV/HCV-coinfected patients naïve to anti-HCV protease inhibitorsSimona Bagaglio, Emanuela Messina, Hamid Hasson, et al.
Pageof 33

Showing results (61-70 of 328) with videos related to

Sort By:
Pageof 33
AIDS (London, England)|December 7, 2006
Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cellsMorgane Bomsel, Claudia Pastori, Daniela Tudor, et al.
AIDS (London, England)|April 13, 2004
Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients: 24-week immunological outcomeNicola Gianotti, Alessandro Soria, Laura Galli, et al.
The New Microbiologica|September 7, 2007
Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapyAnna De Bona, Laura Galli, Giulia Gallotta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2009
Changes in darunavir/r resistance score after previous failure to tipranavir/r in HIV-1-infected multidrug-resistant patientsVincenzo Spagnuolo, Nicola Gianotti, Elena Seminari, et al.
AIDS (London, England)|July 11, 2003
Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administrationSimona Porcellini, Giuliana Vallanti, Silvia Nozza, et al.
Cytometry. Part B, Clinical Cytometry|May 3, 2007
Does cyclosporin A affect CCR5 and CXCR4 expression in primary HIV-1-infected patients?Priscilla Biswas, Andrea Galli, Laura Galli, et al.
Journal of Clinical Microbiology|May 31, 2002
Direct detection of Helicobacter pylori mutations associated with macrolide resistance in gastric biopsy material taken from human immunodeficiency virus-infected subjectsPaolo Scarpellini, Paola Carrera, Annalisa Cavallero, et al.
AIDS (London, England)|September 10, 2003
Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individualsAnna Maria Brambilla, Roberto Novati, Giliola Calori, et al.
HIV Clinical Trials|June 29, 2005
Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in ItalyJohn Hornberger, Jesse Green, Neil Wintfeld, et al.
The New Microbiologica|January 11, 2017
Dynamic change in the NS3 protease domain in HIV/HCV-coinfected patients naïve to anti-HCV protease inhibitorsSimona Bagaglio, Emanuela Messina, Hamid Hasson, et al.
Pageof 33